431 related articles for article (PubMed ID: 26826593)
1. Further evidence for the role of histamine H3, but not H1, H2 or H4, receptors in immepip-induced inhibition of the rat cardioaccelerator sympathetic outflow.
Pinacho-García M; Marichal-Cancino BA; Villalón CM
Eur J Pharmacol; 2016 Feb; 773():85-92. PubMed ID: 26826593
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evidence that histamine H3 receptors inhibit the vasodepressor responses by selective stimulation of the rat perivascular sensory CGRPergic outflow.
Manrique-Maldonado G; Altamirano-Espinoza AH; Marichal-Cancino BA; Rivera-Mancilla E; Avilés-Rosas V; Villalón CM
Eur J Pharmacol; 2015 May; 754():25-31. PubMed ID: 25704614
[TBL] [Abstract][Full Text] [Related]
3. Differential cardiac sympatho-inhibitory responses produced by the agonists B-HT 933, quinpirole and immepip in normoglycaemic and diabetic pithed rats.
Rivera-Mancilla E; Altamirano-Espinoza AH; Manrique-Maldonado G; Villanueva-Castillo B; Villalón CM
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):767-778. PubMed ID: 29675928
[TBL] [Abstract][Full Text] [Related]
4. The role of histamine H
Tamaddonfard E; Erfanparast A; Ghasemi H; Henareh-Chareh F; Hadidi M; Mirzakhani N; Seyedin S; Taati M; Salighedar R; Salimi S; Safaei F
Eur J Pharmacol; 2016 Nov; 791():696-702. PubMed ID: 27693797
[TBL] [Abstract][Full Text] [Related]
5. The role of dopamine D2, but not D3 or D4, receptor subtypes, in quinpirole-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats.
Altamirano-Espinoza AH; González-Hernández A; Manrique-Maldonado G; Marichal-Cancino BA; Ruiz-Salinas I; Villalón CM
Br J Pharmacol; 2013 Nov; 170(5):1102-11. PubMed ID: 24032529
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.
Lozano-Cuenca J; Muñoz-Islas E; González-Hernández A; Centurión D; Cobos-Puc LE; Sánchez-López A; Pertz HH; Villalón CM
Eur J Pharmacol; 2009 Jun; 612(1-3):80-6. PubMed ID: 19356724
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological analysis of the cardiac sympatho-inhibitory actions of moxonidine and agmatine in pithed spontaneously hypertensive rats.
Cobos-Puc LE; Sánchez-López A; Centurión D
Eur J Pharmacol; 2016 Nov; 791():25-36. PubMed ID: 27565220
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Evidence that Histamine H3 Receptors Mediate Histamine-Induced Inhibition of the Vagal Bradycardic Out-flow in Pithed Rats.
García M; García-Pedraza JÁ; Villalón CM; Morán A
Basic Clin Pharmacol Toxicol; 2016 Feb; 118(2):113-21. PubMed ID: 26301462
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological analysis of the inhibition produced by moxonidine and agmatine on the vasodepressor sensory CGRPergic outflow in pithed rats.
Rubio-Beltrán E; Labastida-Ramírez A; Hernández-Abreu O; MaassenVanDenBrink A; Villalón CM
Eur J Pharmacol; 2017 Oct; 812():97-103. PubMed ID: 28694067
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats.
Cobos-Puc LE; Villalón CM; Ramírez-Rosas MB; Sánchez-López A; Lozano-Cuenca J; Gómez-Díaz B; MaassenVanDenBrink A; Centurión D
Eur J Pharmacol; 2009 Aug; 616(1-3):175-82. PubMed ID: 19527708
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological evidence that alpha2A- and alpha2C-adrenoceptors mediate the inhibition of cardioaccelerator sympathetic outflow in pithed rats.
Cobos-Puc LE; Villalón CM; Sánchez-López A; Lozano-Cuenca J; Pertz HH; Görnemann T; Centurión D
Eur J Pharmacol; 2007 Jan; 554(2-3):205-11. PubMed ID: 17109851
[TBL] [Abstract][Full Text] [Related]
12. Chronic 5-HT
García-Pedraza JÁ; Hernández-Abreu O; García M; Morán A; Villalón CM
Can J Physiol Pharmacol; 2018 Apr; 96(4):328-336. PubMed ID: 28886249
[TBL] [Abstract][Full Text] [Related]
13. Further analysis of the inhibition by agmatine on the cardiac sympathetic outflow: Role of the α
Cobos-Puc L; Aguayo-Morales H; Ventura-Sobrevilla J; Luque-Contreras D; Chin-Chan M
Eur J Pharmacol; 2017 Jun; 805():75-83. PubMed ID: 28315344
[TBL] [Abstract][Full Text] [Related]
14. Microinjection of histamine and its H
Salimi S; Tamaddonfard E
Eur J Pharmacol; 2019 Aug; 857():172450. PubMed ID: 31202805
[TBL] [Abstract][Full Text] [Related]
15. The role of purinergic P2Y
Villanueva-Castillo B; Rivera-Mancilla E; Haanes KA; MaassenVanDenBrink A; Villalón CM
Purinergic Signal; 2020 Mar; 16(1):73-84. PubMed ID: 32067141
[TBL] [Abstract][Full Text] [Related]
16. Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats.
Marichal-Cancino BA; Manrique-Maldonado G; Altamirano-Espinoza AH; Ruiz-Salinas I; González-Hernández A; Maassenvandenbrink A; Villalón CM
Eur J Pharmacol; 2013 Dec; 721(1-3):168-77. PubMed ID: 24076186
[TBL] [Abstract][Full Text] [Related]
17. The dopamine receptors mediating inhibition of the sympathetic vasopressor outflow in pithed rats: pharmacological correlation with the D(2) -like type.
Manrique-Maldonado G; González-Hernández A; Marichal-Cancino BA; Villamil-Hernández MT; del Mercado OA; Centurión D; Villalón CM
Basic Clin Pharmacol Toxicol; 2011 Dec; 109(6):506-12. PubMed ID: 21740529
[TBL] [Abstract][Full Text] [Related]
18. The α2-adrenoceptors mediating inhibition of the vasopressor sympathetic outflow in pithed rats: pharmacological correlation with α2A, α2B and α2C subtypes.
Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Centurión D
Eur J Pharmacol; 2013 Oct; 718(1-3):245-52. PubMed ID: 24028939
[TBL] [Abstract][Full Text] [Related]
19. NaHS prejunctionally inhibits the cardioaccelerator sympathetic outflow in pithed rats.
Centurión D; de la Cruz SH; Castillo-Santiago SV; Becerril-Chacón ME; Torres-Pérez JA; Sánchez-López A
Eur J Pharmacol; 2018 Mar; 823():35-40. PubMed ID: 29378194
[TBL] [Abstract][Full Text] [Related]
20. In vitro study of histamine and histamine receptor ligands influence on the adhesion of purified human eosinophils to endothelium.
Grosicki M; Wójcik T; Chlopicki S; Kieć-Kononowicz K
Eur J Pharmacol; 2016 Apr; 777():49-59. PubMed ID: 26939881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
